Literature DB >> 31402575

Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the "real world" everyday clinical practice.

Domenico De Berardis1,2, Michele Fornaro3,4, Alessandro Valchera4,5,6, Gabriella Rapini1, Serena Di Natale1, Ida De Lauretis2, Nicola Serroni2, Laura Orsolini4,5,6, Carmine Tomasetti7, Massimiliano Bustini8, Alessandro Carano9, Federica Vellante2, Giampaolo Perna10,11,12, Laura Core13, Marco Alessandrini2, Silvia Fraticelli2, Giovanni Martinotti2, Massimo Di Giannantonio2.   

Abstract

AIM: The present study is aimed at revaluating alexithymia, somatic sensations, resilience and their relationships with suicide ideation in drug naïve adult outpatients suffering from first episode major depression (MD).
METHODS: Data of 103 adult outpatients (49 men, 56 women) with a diagnostic and statistical manual of mental disorders, 4th edition, text revision (DSM-IV-TR) diagnosis of MD were analysed. Alexithymia was measured using the 20-item Toronto Alexithymia Scale (TAS-20) and resilience with the 25 items Connor-Davidson Resilience Scale (CD-RISC) whereas depression was evaluated using the 17-item Hamilton Depression Rating Scale, somatic sensations with the Body Sensations Questionnaire and suicide ideation with Scale of Suicide Ideation (SSI).
RESULTS: Gender comparisons between all demographic and clinical variables showed no significant differences in all variables. Subjects who were found positive for alexithymia showed higher scores on all clinical variables controlling for age, gender and duration of the current episode. In a linear regression model, lower scores on CD-RISC and Difficulty in Identifying Feelings dimension of TAS-20 were significantly predictive of higher scores on SSI.
CONCLUSIONS: Alexithymia and low resilience were significant predictors of increased suicide ideation in a first MD episode. However, study limitations must be considered and future research needs are being discussed.
© 2019 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  alexithymia; emotions; major depression; resilience; suicide ideation

Mesh:

Substances:

Year:  2019        PMID: 31402575     DOI: 10.1111/eip.12863

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  10 in total

1.  Impact of Alexithymia on the Lipid Profile in Major Depressed Individuals.

Authors:  Camille Point; Benjamin Wacquier; Marjorie Dosogne; Mohammed Al Faker; Hadrien Willame; Gwenolé Loas; Matthieu Hein
Journal:  J Lipids       Date:  2022-06-16

2.  The psychological impact of COVID-19 on the mental health in the general population.

Authors:  Gianluca Serafini; Bianca Parmigiani; Andrea Amerio; Andrea Aguglia; Leo Sher; Mario Amore
Journal:  QJM       Date:  2020-06-22

3.  Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables.

Authors:  Giampaolo Perna; Alessandra Alciati; Silvia Daccò; Massimiliano Grassi; Daniela Caldirola
Journal:  Psychiatry Investig       Date:  2020-03-12       Impact factor: 2.505

4.  Alexithymic Traits and Hair Cortisol Concentrations in Pregnant Women.

Authors:  Jani Kajanoja; Max Karukivi; Paula Mustonen; Noora M Scheinin; Susanna Kortesluoma; Ana João Rodrigues; Hasse Karlsson; Linnea Karlsson
Journal:  Front Psychiatry       Date:  2020-05-13       Impact factor: 4.157

5.  Mothering, Substance Use Disorders and Intergenerational Trauma Transmission: An Attachment-Based Perspective.

Authors:  Florien Meulewaeter; Sarah S W De Pauw; Wouter Vanderplasschen
Journal:  Front Psychiatry       Date:  2019-10-18       Impact factor: 4.157

6.  Influence of Personality, Resilience and Life Conditions on Depression and Anxiety in 104 Patients Having Survived Acute Autoimmune Thrombotic Thrombocytopenic Purpura.

Authors:  Tanja Falter; Sibylle Böschen; Markus Schepers; Manfred Beutel; Karl Lackner; Inge Scharrer; Bernhard Lämmle
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

7.  Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder.

Authors:  Caroline W Grant; Angelina R Wilton; Rima Kaddurah-Daouk; Michelle Skime; Joanna Biernacka; Taryn Mayes; Thomas Carmody; Liewei Wang; Konstantinos Lazaridis; Richard Weinshilboum; William V Bobo; Madhukar H Trivedi; Paul E Croarkin; Arjun P Athreya
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

8.  Genetic underpinnings of affective temperaments: a pilot GWAS investigation identifies a new genome-wide significant SNP for anxious temperament in ADGRB3 gene.

Authors:  Xenia Gonda; Nora Eszlari; Dora Torok; Zsofia Gal; Janos Bokor; Andras Millinghoffer; Daniel Baksa; Peter Petschner; Peter Antal; Gerome Breen; Gabriella Juhasz; Gyorgy Bagdy
Journal:  Transl Psychiatry       Date:  2021-06-01       Impact factor: 6.222

9.  Suicidality Presented to a Child and Adolescent Psychiatry Emergency Service: Increasing Rate and Changing Characteristics.

Authors:  Stephanie Kandsperger; Irina Jarvers; Daniel Schleicher; Angelika Ecker; Michael Wirth; Romuald Brunner
Journal:  Front Psychiatry       Date:  2021-07-15       Impact factor: 4.157

10.  Targeting Epigenetic Mechanisms to Treat Alcohol Use Disorders (AUD).

Authors:  F David Rodriguez
Journal:  Curr Pharm Des       Date:  2021-10-05       Impact factor: 3.116

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.